Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
240 studies found for:    ACRODYSOSTOSIS 2, WITH OR WITHOUT HORMONE RESISTANCE
Show Display Options
Rank Status Study
1 Active, not recruiting Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
Conditions: Breast Cancer;   Breast Neoplasm
Intervention: Drug: Pazopanib
2 Recruiting Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer
Condition: Neoplasms
Interventions: Drug: Fulvestrant;   Drug: Vandetanib
3 Completed Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
Conditions: Hormone Resistant Prostate Cancer;   Metastatic Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine;   Drug: prednisone
4 Completed Effect of Growth Hormone on Insulin Signaling in Muscle Tissue
Condition: Insulin Resistance
Intervention: Device: Physiological Bolus of Growth Hormone
5 Not yet recruiting Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Stage IV Prostate Adenocarcinoma
Interventions: Drug: Cabazitaxel;   Drug: Prednisone
6 Recruiting Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Prostate Carcinoma
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
7 Active, not recruiting
Has Results
Cediranib Maleate With or Without Dasatinib in Patients With Hormone-Resistant Prostate Cancer Resistant to Treatment With Docetaxel
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: cediranib maleate;   Drug: dasatinib;   Procedure: assessment of therapy complications;   Other: laboratory biomarker analysis
8 Completed Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes
Conditions: Diabetes;   Metabolic Syndrome;   Insulin Resistance
Intervention: Drug: pegvisomant
9 Completed
Has Results
Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: oxaliplatin;   Drug: pemetrexed disodium;   Other: questionnaire administration;   Other: laboratory biomarker analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Genetic: polymorphism analysis
10 Recruiting The Influence of Breakfast on Hormone Responses and Cognitive Performance
Condition: Insulin Resistance
Interventions: Other: A= Yes Breakfast;   Other: B=No Breakfast
11 Active, not recruiting Phase II Clinical Trial of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer With Correlative Assessment of Hormone Intermediates.
Condition: Castration-resistant Prostate Cancer
Interventions: Drug: abiraterone acetate;   Drug: prednisone;   Procedure: pre-treatment and progression tumor biopsies;   Genetic: assessment of serum corticosteroid intermediates and ACTH
12 Completed Gut Hormone Response After Paleolithic-type Meals
Conditions: Insulin Resistance;   Satiety
Interventions: Other: PAL-2;   Other: TFH-1;   Other: Reference
13 Unknown  Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight
Condition: Fetal Growth Retardation
Intervention: Drug: somatropin (rDNA)
14 Recruiting Reversing Hormone Therapy Resistance With Epigenetic-Immune Modification
Condition: Breast Neoplasms
Interventions: Drug: Tamoxifen;   Drug: Vorinostat;   Drug: pembrolizumab
15 Completed
Has Results
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Conditions: HIV-Associated Lipodystrophy Syndrome;   Insulin Resistance;   HIV Infections;   Metabolic Syndrome X;   Body Weight Changes
Interventions: Drug: Rosiglitazone;   Drug: Recombinant human growth hormone + rosiglitazone
16 Not yet recruiting Female Sex Hormones, Insulin Resistance and Effects of Exercise in a Human Experimental Model of Menopause
Condition: Metabolic Syndrome
Interventions: Behavioral: exercise;   Drug: Hormone treatment
17 Not yet recruiting Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Castration Levels of Testosterone;   Hormone-Resistant Prostate Cancer;   Microsatellite Instability
Interventions: Biological: Durvalumab;   Other: Laboratory Biomarker Analysis
18 Active, not recruiting Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: mifepristone;   Other: laboratory biomarker analysis;   Other: pharmacological study
19 Active, not recruiting Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Drug: Abiraterone Acetate;   Other: Laboratory Biomarker Analysis;   Drug: Prednisone;   Drug: Veliparib
20 Active, not recruiting Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: abiraterone acetate;   Drug: dasatinib;   Drug: prednisone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.